Pfizer has named Mace Rothenberg, M.D. as Senior Vice President, Clinical Development and Medical Affairs for its Oncology Business.
Pervasis Therapeutics has named Frederic Chereau as it's new CEO.
Antisoma PLC has appointed Eric Dodd as CFO.
Guy Van Meter has joined Adimab as Senior Director, Head of Business Development.
Dr. Kenneth Coleman has been named Chief Scientific Officer at Novexel.
Dr. Peter Sondermann will become Chief Scientific Officer of SuppreMol.
CEO Michael Becker and CFO Christopher Schnittker have announced their resignations to VioQuest.
Dr. Uwe Jacob, a co-founder and previously Chief Scientific Officer at SuppreMol, has been appointed Chief Development Officer.
SuppreMol announced that Dr. Thomas Hecht has been elected Chairman of the Company's Supervisory Board.
Dr. Fritz Melchers and Dr. Falk Nimmerjahn have been appointed to SuppreMol's Scientific Advisory Board.
Harlan W. Waksal, M.D., co-founder of and former senior executive at ImClone, has been elected to the Board of Directors of Senesco Technologies.